Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
9.64
+0.28 (2.99%)
At close: Aug 5, 2025, 4:00 PM
9.69
+0.05 (0.52%)
After-hours: Aug 5, 2025, 7:58 PM EDT
CALT Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$24.71
Upside
+156.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $25 | Buy | Initiates | $25 | +159.34% | Aug 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +107.47% | Aug 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +107.47% | May 9, 2025 |
| Baird | Baird | Buy Maintains $27 → $16 | Buy | Maintains | $27 → $16 | +65.98% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +470.54% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +470.54% | Jan 31, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $23 | Buy | Initiates | $23 | +138.59% | Jan 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +107.47% | Dec 20, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $20 | Buy | Reiterates | $20 | +107.47% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +470.54% | Nov 11, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +45.23% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $55 | Strong Buy | Maintains | $35 → $55 | +470.54% | Aug 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +263.07% | Jul 31, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $36 | Strong Buy | Maintains | $36 | +273.44% | Jul 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 21, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $22 | Buy | Reiterates | $22 | +128.22% | Jun 5, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.